Stocks · Health care · Pharmaceutical Preparations

Whitehawk Therapeutics, Inc.

WHWK Clue Score25
United States Fiscal year ends December CIK 0001422142 Results filed 6 Aug 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Scott M. Giacobello
16 Apr 2026
Chief Financial Officer
Sell
141,600
$4.13
$584.81K
Scott M. Giacobello
15 Apr 2026
Chief Financial Officer
Sell
77,000
$3.86
$297.22K
Bryan Ball
14 Apr 2026
See remarks
Sell
92,460
$3.64
$336.55K
Bryan Ball
13 Apr 2026
See remarks
Sell
26,389
$3.46
$91.31K
Bryan Ball
10 Apr 2026
See remarks
Sell
6,596
$3.43
$22.62K
David James Lennon
9 Apr 2026
Chief Executive Officer
Sell
14,500
$3.38
$49.01K
Bryan Ball
9 Apr 2026
See remarks
Sell
50,000
$3.57
$178.50K
David James Lennon
8 Apr 2026
Chief Executive Officer
Sell
63,945
$3.40
$217.41K
David James Lennon
7 Apr 2026
Chief Executive Officer
Sell
94,087
$3.43
$322.72K
David James Lennon
6 Apr 2026
Chief Executive Officer
Sell
102,395
$3.51
$359.41K
David James Lennon
2 Apr 2026
Chief Executive Officer
Sell
26,858
$3.48
$93.47K
Bryan Ball
2 Mar 2026
See remarks
Sell
1,834
$3.31
$6.07K
Scott M. Giacobello
2 Mar 2026
Chief Financial Officer
Sell
2,594
$3.31
$8.59K
David James Lennon
2 Mar 2026
Chief Executive Officer
Sell
5,100
$3.31
$16.88K

What was left out

Form 4 filings counted 34
Amendments (4/A) skipped 5
Filings about a different issuer 0
Unreadable filings 0
Joint filings 2
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 14
Transactions with no price 0
Shares from compensation/vesting 3,334,312
History held since 17 Mar 2017